Stock Chart
LEGN
Type: SELL growth_1yr
Strike: $20
Premium: $11.70
Expiry: Dec 18, 2026
Target: $19
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About LEGN - Legend Biotech Corporation American Depositary Shares
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Key Statistics
More LEGN Analysis
This LEGN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track LEGN's price movements with trendlines, gamma walls, and key support/resistance levels.